Executive Profile

Ross A. Jaffe M.D. General Partner, Brentwood Venture Capital

Age	Total Calculated Compensation	This person is connected to 5 Board Members in 5 different organizations across 13 different industries. See Board Relationships
52	--

Background

Dr. Ross A. Jaffe, M.D. is Managing Director and Partner at Versant Ventures, Inc. Dr. Jaffe co-founded Versant Venture Capital in 1999 and specializes in early-stage investing in medical devices. He is a Research Associate at Dartmouth Medical School. He has more than 20 years of significant clinical insight and venture capital experience. He joined Brentwood Venture Capital in August 1990. He spent nine years at Brentwood Venture Capital where, as a General Partner, ... and led investments in medical devices, drug delivery, and healthcare information systems companies. As a physician, he has significant clinical experience and insight to Versant’s investing efforts. Before and during medical school, he was an Analyst at Lewin and Associates. He serves as a Director of Minerva Surgical Calypso Medical Technologies, ICS, Portaero, Inc, and Fovioptics. Dr. Jaffe has been a Director of AlterG, Inc. (also known as Alter-G Inc.) since 2009. He serves as a Director of Cerephex, Sympara, Intersection Medical, Inc. and Minerva Surgical Inc. Dr. Jaffe serves as a Director of Portaero, Inc, Micro Interventional Systems, Aradigm, Webster Laboratories, Atrionix, and ProDuct Health. He served as a Director of Vital Therapies, Inc. since September 2007. He served as a Director of CardioNow, Inc., Impedance Cardiology Systems, Inc. and NDO Surgical, Inc. He served as a Director of NovaRay Medical, Inc. and St. Francis Medical Technologies, Inc. He served as a Director Abbott Diabetes Care, Inc. (also known as Therasense Inc.) since October 1998. Dr. Jaffe served as a Director of Insulet Corporation since 2001. He served as a Director of Cytyc Surgical Products, Limited Partnership (also known as Novacept Inc.) since 1998. He served as a Director of Acclarent, Inc. since January 2005. He served as Director of SmartTalk, Inc., Calypso Medical Technologies, Inc., and Ablation Frontiers L.L.C. He chairs the Board of the Children's Health Council (Palo Alto, CA), and serves on the Board of Advisors of the Dartmouth Institute for Health Policy & Clinical Practice. Dr. Jaffe served as a Director of National Venture Capital Association and Western Association of Venture Capitalists (WAVC). He is a Board-Certified Internist, having completed his residency training in Internal Medicine and Primary Care at the University of California, San Francisco., where he remained a part-time attending physician until 1995. He is on the Board of Overseers at Dartmouth Medical School and on the Board of Advisors of Ravenswood Family health Center. He has been recognized as a leading venture capitalist, including being the highest ranked medical device investor on Forbes Magazines’ 2011 “Midas List“ of the top 100 venture capitalists. Dr. Jaffe received an M.B.A. from Stanford University in 1990, an M.D. from the Johns Hopkins University School of Medicine in 1985, and an A.B. in Policy Studies from Dartmouth College in 1980.

Corporate Headquarters 3000 Sand Hill Road Building 1 Menlo Park, California 94025 United States Phone: 650-854-7691 Fax: 650-854-9513 Board Members Memberships Former Director NovaRay Medical, Inc. Director SmartTalk, Inc. Former Member of the Board of Directors, Member of Nominating & Governance Committee and Member of Compensation Committee St. Francis Medical Technologies, Inc. Director Calypso Medical Technologies, Inc. Former Director CardioNow, Inc. Former Director NDO Surgical, Inc. Director National Venture Capital Association Director Western Association of Venture Capitalists Director Ablation Frontiers L.L.C. Director Impedance Cardiology Systems, Inc. Director Portaero, Inc Director Minerva Surgical Inc. Director Intersection Medical, Inc. 1998-N/A Director Cytyc Surgical Products, Limited Partnership 1998-Present Director Abbott Diabetes Care, Inc. 2001-N/A Former Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee Insulet Corporation 2005-N/A Member of Nominating & Governance Committee Acclarent, Inc. 2007-N/A Former Director Vital Therapies, Inc. 2009-Present Director AlterG, Inc. Education MBA 1990 Stanford University BA 1980 Dartmouth College MD 1985 Johns Hopkins School of Medicine Other Affiliations NovaRay Medical, Inc. Cytyc Surgical Products, Limited Partnership SmartTalk, Inc. Abbott Diabetes Care, Inc. Versant Ventures, Inc. St. Francis Medical Technologies, Inc. Stanford University Insulet Corporation Calypso Medical Technologies, Inc. CardioNow, Inc. NDO Surgical, Inc. Brentwood Associates IX, L.P. Versant Venture Capital II, L.P. Dartmouth College Johns Hopkins University National Venture Capital Association Vital Therapies, Inc. Johns Hopkins School of Medicine Western Association of Venture Capitalists Versant Venture Capital III, L.P. Acclarent, Inc. Ablation Frontiers L.L.C. Impedance Cardiology Systems, Inc. AlterG, Inc. Versant Venture Capital IV, L.P. Portaero, Inc Minerva Surgical Inc. Intersection Medical, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.